From
- Psychedelic Spotlight surpassed and consistently maintained more than half-a-million page view average for the site
PSYC Media Services launched full monetization efforts resulting in nearly$25,000 USD in gross revenue- Achieved top rank on
Google for “psychedelic news” - Psychedelic Spotlight’s YouTube channel successfully met YouTube’s criteria for monetization capabilities
- Psychedelic Spotlight team added
Christopher Porszt , an experienced sales executive fromToronto Canada to help maximize sales and monetization efforts throughout 2022 - The Company repaid the total outstanding balance of
$112,000 USD associated with a convertible promissory note datedNovember 18, 2020
The above content in not intended as a representation in the purchase or sale of our securities nor is there any assurance that past performance is indicative of future results.
“As much of an uphill battle 2021 was at times, I am truly inspired by the way we closed out the year and believe it demonstrates the dynamic progress we continue to make as a Company,” said PSYC CEO,
About
At
PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major
We are dedicated to a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19 and the success of the current vaccine distribution, the adverse effect of the Omicron variant, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website and is not incorporated by reference into such reports.
Disclaimer:
Corporate Contact:
www.globaltracsolutions.com
(702) 239-1919
psyc@globaltracsolutions.com
OTCPINK: PSYC
Source:
2022 GlobeNewswire, Inc., source